CN115252732A - 一种清肺止咳的中药组合物及其应用 - Google Patents
一种清肺止咳的中药组合物及其应用 Download PDFInfo
- Publication number
- CN115252732A CN115252732A CN202210670878.0A CN202210670878A CN115252732A CN 115252732 A CN115252732 A CN 115252732A CN 202210670878 A CN202210670878 A CN 202210670878A CN 115252732 A CN115252732 A CN 115252732A
- Authority
- CN
- China
- Prior art keywords
- parts
- cough
- lung
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 94
- 206010011224 Cough Diseases 0.000 title claims abstract description 93
- 210000004072 lung Anatomy 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 229940079593 drug Drugs 0.000 claims abstract description 29
- 235000020251 goat milk Nutrition 0.000 claims abstract description 24
- 244000272264 Saussurea lappa Species 0.000 claims abstract description 23
- 235000006784 Saussurea lappa Nutrition 0.000 claims abstract description 23
- 241000935235 Fritillaria meleagris Species 0.000 claims abstract description 22
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 21
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 21
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 21
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 20
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 20
- 240000000249 Morus alba Species 0.000 claims abstract description 19
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 19
- 241000596154 Belamcanda Species 0.000 claims abstract description 18
- 241000735527 Eupatorium Species 0.000 claims abstract description 18
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 18
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 18
- 235000011477 liquorice Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 241001633680 Polygonatum odoratum Species 0.000 claims abstract description 17
- 241000490229 Eucephalus Species 0.000 claims abstract description 12
- 241000249864 Tussilago Species 0.000 claims abstract description 10
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 6
- 235000004869 Tussilago farfara Nutrition 0.000 claims description 18
- 240000000377 Tussilago farfara Species 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000006673 asthma Diseases 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 15
- 206010036790 Productive cough Diseases 0.000 abstract description 10
- 230000002411 adverse Effects 0.000 abstract description 9
- 230000001105 regulatory effect Effects 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 32
- 208000026435 phlegm Diseases 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 18
- 239000000463 material Substances 0.000 description 16
- 230000000670 limiting effect Effects 0.000 description 15
- 241001092070 Eriobotrya Species 0.000 description 14
- 238000002156 mixing Methods 0.000 description 14
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 229930003935 flavonoid Natural products 0.000 description 12
- 150000002215 flavonoids Chemical class 0.000 description 12
- 235000017173 flavonoids Nutrition 0.000 description 12
- 230000000144 pharmacologic effect Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 229930013930 alkaloid Natural products 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 239000000341 volatile oil Substances 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- 150000003797 alkaloid derivatives Chemical class 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 238000010926 purge Methods 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 238000002791 soaking Methods 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 241001671204 Stemona Species 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 239000002398 materia medica Substances 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000000840 anti-viral effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 230000000954 anitussive effect Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 229940124584 antitussives Drugs 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- -1 phenylpropanoid glycosides Chemical class 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000756042 Polygonatum Species 0.000 description 3
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 206010047924 Wheezing Diseases 0.000 description 3
- 230000001088 anti-asthma Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000000924 antiasthmatic agent Substances 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 235000001671 coumarin Nutrition 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002212 flavone derivatives Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 238000003359 percent control normalization Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 241000308663 Eupatorium fortunei Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 235000013717 Houttuynia Nutrition 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000132004 Symphyotrichum cordifolium Species 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000002601 radiography Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241001313857 Bletilla striata Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000209020 Cornus Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 241001547125 Fritillaria thunbergii Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 229930182496 polymethoxyflavone Natural products 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 229930002600 steroidal saponin Natural products 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种清肺止咳的中药组合物及其应用,中药组合物由以下重量份的原料药制成:羊乳10‑20份,桑白皮25‑35份,浙贝10‑20份,鱼腥草15‑25份,枇杷叶5‑15份,甘草3‑9份,百部10‑20份,玉竹15‑25份,紫菀8‑16份,射干3‑9份,款冬花3‑9份,佩兰4‑12份,地龙3‑9份,陈皮3‑9份,广木香2‑8份。本发明的中药组合物全方功专止嗽平喘、清肺降逆,兼理气燥湿,能够改善咳嗽咳痰气喘不适等症状。
Description
技术领域
本发明涉及中医药技术领域,具体而言,涉及一种清肺止咳的中药组合物及其应用。
背景技术
肺是人体的最重要的免疫器官之一,在现今社会,每个人的肺部健康都容易受到许多外部威胁,如吸烟、环境污染、有害气体、病毒等,肺系疾患的主要证候之一就是咳嗽。肺热咳嗽是由于肺内郁热、肺气失宣出现以咳嗽为主的一种症候,多见于免疫力低下的儿童及老人,从中医学范畴上讲,肺热咳嗽属于温病学。现代医学中的呼吸道感染、急慢性支气管炎发作等呼吸系统疾病都有可能出现本病症,临床主要表现为反复咳嗽、咳痰、气喘不适,伴有口干、咽痛、便秘、尿赤、身热等症状。
西医上大多采用抗生素和止咳药治疗咳嗽,有一定治疗效果,但无法根除肺部疾病,且有一定副作用和依赖性。中医药治疗肺热咳嗽有其独特优势,根据肺的特性最大限度地减轻乃至消除有害物质对肺脏的损害,提高肺的抗病能力和健康水平。但现有的治疗咳嗽的中药种类繁多,治疗效果有待提高,常会含有一些名贵药材,增加了治疗成本。
发明内容
本发明的目的之一是提供一种能够改善咳嗽、咳痰、气喘不适等症状的中药组合物。
本发明的上述目的可通过以下技术方案实现:
一种清肺止咳的中药组合物,由以下重量份的原料药制成:羊乳10-20份,桑白皮25-35份,浙贝10-20份,鱼腥草15-25份,枇杷叶5-15份,甘草3-9份,百部10-20份,玉竹15-25份,紫菀8-16份,射干3-9份,款冬花3-9份,佩兰4-12份,地龙3-9份,陈皮3-9份,广木香2-8份。
优选地,上述清肺止咳的中药组合物由以下重量份的原料药制成:羊乳12-18份,桑白皮28-32份,浙贝12-18份,鱼腥草18-22份,枇杷叶8-12份,甘草5-7份,百部12-18份,玉竹18-22份,紫菀10-14份,射干5-7份,款冬花5-7份,佩兰6-10份,地龙5-7份,陈皮5-7份,广木香4-6份。
优选地,上述清肺止咳的中药组合物由以下重量份的原料药制成:羊乳12-18份,桑白皮28-32份,浙贝12-18份,鱼腥草18-22份,枇杷叶8-12份,甘草5-7份,百部12-18份,玉竹18-22份,紫菀10-14份,射干5-7份,款冬花5-7份,佩兰6-10份,地龙5-7份,陈皮5-7份,广木香4-6份。
优选地,上述清肺止咳的中药组合物包括医学能够接受的药物载体。
本发明的另一个目的在于公开上述中药组合物在制备治疗肺热咳嗽的药物中的应用。
优选地,上述药物的剂型为颗粒剂、口服液、片剂、胶囊、散剂、丸剂或膏方。
本发明的有益效果如下:
本发明的中药组合物以中医经典为理论支持,组方合理,配伍得当,全方功专止嗽平喘、清肺降逆,兼理气燥湿,能够改善咳嗽咳痰气喘不适等症状。
本发明的中药组合物可用于制备治疗肺热咳嗽的药物,药物可选择多种剂型,在保证疗效的同时,具有了治疗方便,药效长久,药物可随身携带,疗效稳定,药物经济性强等优点。
具体实施方式
下面将结合实施例对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明一种实施方式为清肺止咳的中药组合物,中药组合物由以下原料药制成:羊乳,桑白皮,浙贝,鱼腥草,枇杷叶,甘草,百部,玉竹,紫菀,射干,款冬花,佩兰,地龙,陈皮,广木香。
本发明方义如下:
君药:羊乳、浙贝、地龙。羊乳:甘、辛,性平,归脾、肺经。益气养阴、解毒消肿、排脓通乳。《别录》:“主头眩痛,益气,长肌肉”。浙贝:苦,性寒,归肺、心经。清热化痰止咳、解毒散结消痈。《本草正》:“最降痰气,善开郁结,止疼痛,消胀满”。地龙:咸,性寒,归肝、脾、膀胱经。清热平肝、息风止痉、平喘利尿、通络除痹。《滇南本草》:“祛风,治小儿瘈疭惊风”。《科学的民间药草》:“解热、利尿、舒展支气管作用,可治气喘等”。三者合用,止咳平喘,化痰散结。
臣药:百部、枇杷叶、桑白皮、鱼腥草。百部:甘、苦,性微温,归肺经。润肺下气止咳、杀虫灭虱。《名医别录》:“主咳嗽上气”。枇杷叶:苦、微辛,性微寒,入肺、胃经。清肺止咳、和胃降逆、止渴。《本草汇言》:“安胃气,润心肺,养肝肾之药也”。桑白皮:味甘辛,性寒,归肺、脾经。泻肺平喘、利尿消肿。《本草备要》:“泻肺火,利二便,散瘀血,下气行水,止嗽清痰”。鱼腥草:辛,性微寒,归肺经。清热解毒、消痈排脓、利尿通淋。《滇南本草》:“治肺痈咳嗽带脓血,痰有腥臭,大肠热毒”。四者辅佐君药,助其清肺止咳之效。君臣相伍,功可止咳化痰,清肺降逆。
佐药:紫菀、款冬花、玉竹、射干、佩兰、陈皮、广木香。紫菀:辛、苦,性温,归肺经。润肺下气、消痰止咳。《本草备要》:“辛温润肺,苦温下气。补虚调中,消痰止渴”。款冬花:性辛温,味微苦,归肺经。润肺下气、止咳化痰平喘。《本草备要》:“泻热润肺,消痰除烦”。玉竹:甘,性平,归肺、胃经。养阴润燥、生津止渴。《日华子本草》:“除烦闷,止渴,润心肺,补五劳七伤”。射干:苦,性寒,归肺经。清热解毒、消痰、利咽。《景岳全书》:“治咳逆上气,喉痹咽疼”。佩兰:微苦,气芳香,性辛平,归脾、胃、肺经。芳香化湿、醒脾开胃、发表解暑。《素问》:“治之以兰,除陈气也”。《本草经疏》:“开胃除恶,清肺消痰,散郁结之圣药也”。陈皮:苦、辛,性温,归肺、脾经。理气健脾、燥湿化痰。《日用本草》:“能散能泻,能温能补,能消膈气,化痰涎,和脾止嗽”。《本草汇言》:“如欲调气健脾者,橘皮之功居其首焉”。广木香:辛、苦,性温,归脾、胃、大肠、三焦、胆经。行气止痛、健脾消食。《本草纲目》:“和胃气,泄肺气,行肝气。凡气郁而不舒者,宜用之”。《本草求真》:“下气宽中,为三焦气分要药”。
使药:甘草。甘草:甘,性平,归心、肺、脾、胃经。补脾益气、祛痰止咳、缓急止痛、调和诸药。《药性赋》:“生则分身梢而泻火,炙则健脾胃而和中。解百毒而有效,协诸药而无争,以其甘能缓急,故有国老之称。”
本药方旨在止嗽平喘、清肺降逆,兼理气燥湿,能够改善咳嗽咳痰气喘不适等症状。
中药组合物中原料药的重量份及药理作用如下:
羊乳10-20份,桑白皮25-35份,浙贝10-20份,鱼腥草15-25份,枇杷叶5-15份,甘草3-9份,百部10-20份,玉竹15-25份,紫菀8-16份,射干3-9份,款冬花3-9份,佩兰4-12份,地龙3-9份,陈皮3-9份,广木香2-8份。
羊乳:味甘、辛,性平益气养阴、解毒消肿、排脓通乳。羊乳主要含有三萜皂苷类、生物碱类、苯丙醇苷类等化学成分。现代药理学研究表明,羊乳具有抗氧化、改善记忆;镇静、镇痛、抗惊厥作用;保肝、醒酒作用;抗炎,降低血脂、胆固醇,抗癌、抗突变;抗血小板凝集、抗血栓;降低血糖、调节免疫等药理作用。羊乳典型但非限制性的含量为:10份、11份、12份、13份、14份、15份、16份、17份、18份、19份、20份。
桑白皮:性甘、寒,泻肺平喘、利尿消肿。富含生物碱类、黄酮类、黄烷醇类、花色素类、苯并呋喃类、酚酸类、多糖类等化学成分。目前的研究表明,桑白皮除传统功效所对应的镇咳、祛痰、平喘、利尿等药理作用外,还具有镇痛、抗炎、降血糖、舒张心血管、抗病毒、抗癌、免疫调节、抗氧化、抗过敏等多种药理作用,其中桑白皮总黄酮具有较强的药理活性。桑白皮典型但非限制性的含量为:25份、26份、27份、28份、29份、30份、31份、32份、33份、34份、35份。
浙贝:味苦,性寒,清热化痰止咳、解毒散结消痈。浙贝母主要化学成分包括生物碱、多糖、总皂苷、黄酮类成分和挥发性成分等,具有止咳祛痰平喘、镇痛抗炎、抗溃疡、抗氧化、抗肿瘤及逆转肿瘤细胞耐药等功能。浙贝典型但非限制性的含量为:10份、11份、12份、13份、14份、15份、16份、17份、18份、19份、20份。
鱼腥草:辛,微寒,清热解毒、消痈排脓、利尿通淋。鱼腥草主要有效成分为挥发油和黄酮,还有生物碱、多糖、有机酸类等活性成分。药理研究证明其具有抗菌、抗病毒、抗炎、增强机体免疫功能、抗肿瘤、抗过敏、平喘及镇咳等作用。鱼腥草典型但非限制性的含量为:15份、16份、17份、18份、19份、20份、21份、22份、23份、24份、25份。
枇杷叶:味苦、微辛,性微寒,清肺止咳、和胃降逆、止渴。枇杷叶主要含有黄酮类、三萜酸类、有机酸类、挥发油类等化学成分,有效成分主要为乌索酸、黄酮类化合物和苦杏仁苷。具有抗炎、祛痰、止咳、抗病毒、抗肺纤维化、抗氧化、降血糖、抗肿瘤、止呕等药理作用。枇杷叶典型但非限制性的含量为:5份、6份、7份、8份、9份、10份、11份、12份、13份、14份、15份。
甘草:性平,味甘,补脾益气、清热解毒、祛痰止咳、缓急止痛、调和诸药。甘草主要含有三萜类、黄酮类、多糖类、香豆素类、挥发油类、氨基酸等化学成分,其中三萜类和黄酮类是主要成分。具有抗肿瘤、抗菌、抗病毒、抗炎、抗哮喘、抗氧化、调节免疫、抗纤维化、保肝、降糖、抗溃疡、止痒、解痉等多种药理活性。甘草典型但非限制性的含量为:3份、4份、5份、6份、7份、8份、9份。
百部:味甘、苦,性微温,润肺下气止咳、杀虫灭虱。主要含有百部生物碱,百部还含有茋类、去氢苯并呋喃醇类、绿原酸类、类鱼藤酮类、醌类和香豆素类等非生物碱类成分。具有镇咳、祛痰、杀虫、抗菌、抗氧化、松弛支气管平滑肌等药理作用。百部典型但非限制性的含量为:10份、11份、12份、13份、14份、15份、16份、17份、18份、19份、20份。
玉竹:味甘,性平,养阴润燥、生津止渴。化学成分主要为甾体皂苷类、高异黄酮类、多糖类及挥发油类等化合物。现代药理学研究表明其具有抗炎、抑菌、降血糖、免疫调节、抗氧化、抗衰老、抗肿瘤、护肝、抗疲劳等药理作用。玉竹典型但非限制性的含量为:15份、16份、17份、18份、19份、20份、21份、22份、23份、24份、25份。
紫菀:味辛、苦,性温,润肺下气、消痰止咳。紫菀的化学成分有萜类、肽类、黄酮类、蒽醌类、香豆素类、甾醇及有机酸类等。其药理学作用十分广泛,有抗菌、抗肿瘤、镇咳、祛痰、平喘、抗病毒、抗氧化活性等作用。紫菀典型但非限制性的含量为:8份、9份、10份、11份、12份、13份、14份、15份、16份。
射干:苦,寒,清热解毒、消痰、利咽。射干中含有黄酮类、挥发油、酚酸类、甾类及三萜类等多种活性成分,具有抗炎、抗菌、抗病毒、抗肿瘤、止咳及神经保护等药理活性。射干典型但非限制性的含量为:3份、4份、5份、6份、7份、8份、9份。
款冬花:性辛温,味微苦,润肺下气、止咳化痰平喘。款冬花主要生物活性成分有挥发油类、酚酸类、黄酮类、多糖类、甾醇类、生物碱类、萜类。款冬花具有止咳、平喘、升压、抗炎等药理活性,用于咳嗽、气喘、抗血小板聚集、抗炎、抗过敏、抗肿瘤等。款冬花典型但非限制性的含量为:3份、4份、5份、6份、7份、8份、9份。
佩兰:气芳香,味微苦,性味辛、平,芳香化湿、醒脾开胃、发表解暑。佩兰的主要有效成分是挥发油,还有黄酮和生物碱。具有抑菌抗炎和抗病毒作用、祛痰、抗癌、增强免疫力、胃肠道作用、兴奋平滑肌。佩兰典型但非限制性的含量为:4份、5份、6份、7份、8份、9份、10份、11份、12份。
地龙:性寒,味咸,清热平肝、息风止痉、平喘利尿、通络除痹。主要活性成分为蛋白质、高度不饱和脂肪酸、脂类、核苷酸、微量元素、氨基酸和酶类等。主要药理作用为抗血栓、抗癌、抗氧化、抗心律失常、免疫调节、降压平喘等。地龙典型但非限制性的含量为:3份、4份、5份、6份、7份、8份、9份。
陈皮:味苦、辛,性温,理气健脾、燥湿化痰。主要药效成分为黄酮类(陈皮苷、陈皮多甲氧基黄酮、川陈皮素)、挥发油(柠檬烯)、生物碱类(辛弗林)。陈皮中黄酮类成分具有显著的肝保护及肿瘤抑制作用,陈皮挥发油及生物碱类成分则在呼吸系统疾病的防治中发挥着积极作用。陈皮典型但非限制性的含量为:3份、4份、5份、6份、7份、8份、9份。
广木香:用于胸胁、脘腹胀痛,泻痢后重,食积不消,不思饮食。煨木香实肠止泻。用于泄泻腹痛。成分包括萜类、生物碱、蒽醌、黄酮等。药理学研究发现,木香具有抗炎、抗肿瘤、促进胃动力、降血压和抗血液凝集等作用。广木香典型但非限制性的含量为:2份、3份、4份、5份、6份、7份、8份。
本发明的另一种实施方式为治疗肺热咳嗽的药物,将上述清肺止咳的中药组合物和药学上可接受的辅料加工成为药物。药物的剂型为颗粒剂、口服液、片剂、胶囊、散剂、丸剂、膏方中的任意一种。
下面将结合具体实施例对本发明的技术方案进行进一步地说明。
实施例1
一种清肺止咳的中药组合物,包括如下重量组分的原料药:羊乳15g,桑白皮30g,浙贝15g,鱼腥草20g,枇杷叶10g,甘草6g,百部15g,玉竹20g,紫菀12g,射干6g,款冬花6g,佩兰8g,地龙6g,陈皮6g,广木香5g。
制备及服用方法:药材用250ml清水浸泡半小时,大火煮沸后,再文火煎煮30分钟,取头煎,再加150ml水煎煮20分钟,取二煎,两煎和匀,分早晚两次服用,7天为一疗程。
实施例2
一种清肺止咳的中药组合物,包括如下重量组分的原料药:羊乳16g,桑白皮28g,浙贝16g,鱼腥草21g,枇杷叶10g,甘草6g,百部15g,玉竹20g,紫菀10g,射干6g,款冬花6g,佩兰6g,地龙8g,陈皮6g,广木香5g。
制备及服用方法:药材用250ml清水浸泡半小时,大火煮沸后,再文火煎煮30分钟,取头煎,再加150ml水煎煮20分钟,取二煎,两煎和匀,分早晚两次服用,7天为一疗程。
实施例3
一种清肺止咳的中药组合物,包括如下重量组分的原料药:羊乳20份,桑白皮28份,浙贝15份,鱼腥草22份,枇杷叶12份,甘草6份,百部12份,玉竹18份,紫菀16份,射干9份,款冬花9份,佩兰12份,地龙9份,陈皮9份,广木香8份。
制备方法:将上述药材按用量称取后,加水使浸没药材,浸泡3小时后,加热至沸,煎煮0.5小时,取煎液。药渣依法煎煮2-3次,合并各煎液。过滤后,蒸发浓缩(1:1),冷却后加入1.5倍量的乙醇,充分混匀,放置过夜,取上清,沉淀物用少量50%乙醇洗净,洗液与滤液合并,减压回收乙醇后,浓缩冷却静置,滤过后,真空低温浓缩至稠膏,稠膏比重为1.33,喷雾干燥后过300目筛,加入适量辅料后制成颗粒即可。
实施例4
一种清肺止咳的中药组合物,包括如下重量组分的原料药:羊乳18份,桑白皮32份,浙贝15份,鱼腥草18份,枇杷叶12份,甘草7份,百部16份,玉竹18份,紫菀10份,射干7份,款冬花7份,佩兰9份,地龙5份,陈皮5份,广木香6份。
制备方法:将上述药材按用量称取后,取其药量的五分之三粉碎过50目筛后,加水使浸没药材,浸泡3小时后,加热至沸,煎煮0.5小时,取煎液。药渣依法煎煮2-3次,合并各煎液。过滤后,蒸发浓缩(1:1),冷却后加入1.5倍量的乙醇,充分混匀,放置过夜,取上清,沉淀物用少量50%乙醇洗净,洗液与滤液合并,减压回收乙醇后,浓缩冷却静置,滤过后,真空低温浓缩至稠膏,稠膏比重为1.33喷雾干燥研细过300目筛,得提取物粉末,填充制成胶囊剂。
实施例5
一种清肺止咳的中药组合物,包括如下重量组分的原料药:羊乳12份,桑白皮28份,浙贝12份,鱼腥草18份,枇杷叶8份,甘草6份,百部18份,玉竹22份,紫菀12份,射干6份,款冬花6份,佩兰10份,地龙5份,陈皮5份,广木香6份。
制备方法:按照上述重量称取原料药后干燥,超微粉碎至800目以上的微粒,加入适量糊精搅拌均匀后制成片剂。
实施例6
一种清肺止咳的中药组合物,包括如下重量组分的原料药:羊乳17份,桑白皮30份,浙贝17份,鱼腥草21份,枇杷叶11份,甘草7份,百部16份,玉竹21份,紫菀13份,射干6份,款冬花5份,佩兰8份,地龙7份,陈皮7份,广木香5份。
制备方法:将上述药材按用量称取后,加水使浸没药材,浸泡3小时后,加热至沸,煎煮0.5小时,取煎液。药渣依法煎煮2-3次,合并各煎液。过滤后,蒸发浓缩(1:1),冷却后加入1.5倍量的乙醇,充分混匀,放置过夜,取上清,沉淀物用少量50%乙醇洗净,洗液与滤液合并,减压回收乙醇后,浓缩冷却静置,滤过后,真空低温浓缩至比重为1.20-1.35流浸膏;将第二次药渣干燥后,粉碎成药渣细粉作为填加剂,将药渣细粉与上述比重1.20-1.35的流浸膏搅拌混合均匀,形成混合物,以水蒸汽气体或氮气为雾化气体,进行喷雾干燥,生成药粉颗粒。
对比例1
一种中药组合物,包括如下重量组分的原料药:桑白皮35g,浙贝20g,鱼腥草20g,枇杷叶12g,甘草6g,百部15g,玉竹20g,紫菀12g,射干6g,款冬花6g,佩兰8g,地龙9g,陈皮6g,广木香5g。
制备及服用方法:药材用250ml清水浸泡半小时,大火煮沸后,再文火煎煮30分钟,取头煎,再加150ml水煎煮20分钟,取二煎,两煎和匀,分早晚两次服用,7天为一疗程。
对比例2
一种中药组合物,包括如下重量组分的原料药:羊乳20g,桑白皮30g,浙贝20g,鱼腥草25g,枇杷叶15g,甘草6g,玉竹20g,紫菀10g,射干6g,款冬花6g,佩兰6g,地龙8g,陈皮6g,广木香5g。
制备及服用方法:药材用250ml清水浸泡半小时,大火煮沸后,再文火煎煮30分钟,取头煎,再加150ml水煎煮20分钟,取二煎,两煎和匀,分早晚两次服用,7天为一疗程。
对比例3
白芨颗粒,10g/次,一日三次,7天为一疗程。
临床试验
1.研究对象
选取2019年01月到2022年01月,于宁波市第一医院中医科门诊咳嗽患者130例,年龄为35-65岁,平均为(46.3±8.3岁),所有患者均经临床症状体征评估、血常规、胸片或胸部CT确定是咳嗽,咳嗽的时间为0.1-8月,平均(1.6±1.2月),将130例患者按入院先后次序随机分为五组,包括2组观察组和3组对照组,每组26例,五组患者在年龄、性别、病情、病程等基本资料方面差异均无统计学意义(P>0.05),可展开对比。
2.执行标准及方法
(1)诊断标准
①治愈:咳嗽停止,痰液正常,无呼吸不适感,其他症状消失,不复发;
②好转:咳嗽明显减少,痰液明显改变,停药后复发较轻;
③无效:症状同施治前无明显差异。
(2)治疗方法:
观察组1-2分别用实施例1-2的中药组合物进行治疗,对照组1-2分别用对比例1-2的中药组合物进行治疗,对照组3用对比例3的西药进行治疗,观察组和对照组均治疗4个疗程。
3.研究结果
(1)疗效评价
如表1所示,观察组和对照组比较P<0.05,有统计学意义,观察组的疗效更加明显。
表1观察组和对照组临床疗效比较表
组别 | n | 治愈 | 好转 | 无效 | 总有效率 |
观察组1 | 26 | 11(42.31%) | 12(46.15%) | 3(11.54%) | 88.46% |
观察组2 | 26 | 9(34.62%) | 13(50.00%) | 4(15.38%) | 84.62% |
对照组1 | 26 | 7(26.92%) | 9(34.62%) | 10(38.46%) | 61.54% |
对照组2 | 26 | 6(26.08%) | 11(42.31%) | 9(34.62%) | 65.38% |
对照组3 | 26 | 5(19.23%) | 9(34.62%) | 12(46.15%) | 53.85% |
观察组1-2使用本发明中药组合物治疗咳嗽,疗效要优于对照组3的西药。
对照组1的中药组合物中减少了一味君药羊乳,其功效明显降低。肺阴不足及燥热伤肺会致咳嗽气喘,羊乳能清解热毒,又擅排脓,说明了益气养阴具有止咳平喘的作用。
对照组2组合物中减少一味臣药百部,其功效亦明显降低。百部能抑制咳嗽反射,降低呼吸中枢的兴奋性而具镇咳之效。
(2)安全性评价指标
两组均未见明显不良反应。
研究结果表明:本发明中药复方可改善咳嗽症状,且无明显不良反应,具有较好的安全性。
典型案例
病例1:涂某,男,67岁,已婚,2021年11月12日初诊。主诉:感冒咳嗽40日。现病史:受凉后咳嗽,逐渐加重。咳嗽呈规律性,每晚睡前一小时及晨起后剧烈咳嗽,疲倦乏力,欲呕,吐泡沫样痰,发作时胸闷。服用西药治疗未见明显缓解。舌红润,苔白微腻,脉弦缓。既往史:高血压20余年,血压控制尚可,无其他慢性病传染病史、无过敏史、无手术史等。辅助检查:血、尿常规、心电图及胸部拍片检查,均未见异常。诊断为咳嗽、喘证,辨证分型为痰湿内蕴证,肺脾素虚,外邪与内湿相合,湿邪乘肺,治疗以清肺化痰、降逆止咳为基本治疗原则。用本发明中药方剂进行治疗。每日1剂,药液300ml早晚2次温服。根据患者的症状进行药物加减,患者服上方后,咳嗽较前轻,夜间咳嗽时间明显缩短,以后以上方为基础,2021年12月8日就诊,患者咳嗽基本已平,有时外出遇寒风吹时偶见。嘱定期就诊,不适随诊。后期随访,病愈。
病例2:胡某,男,58岁,已婚,2021年12月6日初诊。主诉:咳嗽咳痰喘息2月余。现病史:喉中喘息痰鸣有声,呼吸急促,咳嗽,痰多粘稠,呈灰白色。予西医解痉止咳平喘,抗炎乃激素治疗后好转,但气促痰多无缓解,至中医就诊,刻下喉间痰鸣,呼吸急促。舌质红,苔薄白,脉滑。既往史:慢性阻塞性肺病5余年,高脂血症8年,无其他慢性病传染病史、无过敏史、无手术史等。辅助检查:胸部CT:慢性支气管炎,肺气肿。血、尿常规、心电图均未见异常。诊断为咳嗽、喘证,辨证分型为痰瘀阻肺证,治疗以清肺平喘、化痰止咳祛瘀为基本治疗原则。用本发明中药方剂进行治疗。每日1剂,药液300ml早晚2次温服。根据患者的症状进行药物加减,患者服上方后,诉气促好转,咳嗽咳痰明显减少,以后以上方为基础,服上方四周后,2022年1月5日就诊,患者症状已缓解,未诉气促痰鸣。嘱定期就诊,不适随诊。后期随访,至今平稳。
虽然本公开披露如上,但本公开的保护范围并非仅限于此。本领域技术人员,在不脱离本公开的精神和范围的前提下,可进行各种变更与修改,这些变更与修改均将落入本发明的保护范围。
Claims (6)
1.一种清肺止咳的中药组合物,其特征在于,由以下重量份的原料药制成:羊乳10-20份,桑白皮25-35份,浙贝10-20份,鱼腥草15-25份,枇杷叶5-15份,甘草3-9份,百部10-20份,玉竹15-25份,紫菀8-16份,射干3-9份,款冬花3-9份,佩兰4-12份,地龙3-9份,陈皮3-9份,广木香2-8份。
2.根据权利要求1所述的清肺止咳的中药组合物,其特征在于,由以下重量份的原料药制成:羊乳12-18份,桑白皮28-32份,浙贝12-18份,鱼腥草18-22份,枇杷叶8-12份,甘草5-7份,百部12-18份,玉竹18-22份,紫菀10-14份,射干5-7份,款冬花5-7份,佩兰6-10份,地龙5-7份,陈皮5-7份,广木香4-6份。
3.根据权利要求2所述的清肺止咳的中药组合物,其特征在于,由以下重量份的原料药制成:羊乳14-16份,桑白皮29-31份,浙贝14-16份,鱼腥草19-21份,枇杷叶10-11份,甘草6-7份,百部14-16份,玉竹19-21份,紫菀12-13份,射干6-7份,款冬花6-7份,佩兰8-9份,地龙6-7份,陈皮6-7份,广木香5-6份。
4.根据权利要求1所述的清肺止咳的中药组合物,其特征在于,包括医学能够接受的药物载体。
5.根据权利要求1-4任一所述的中药组合物在制备治疗肺热咳嗽的药物中的应用。
6.根据权利要求5所述的应用,其特征在于,所述药物的剂型为颗粒剂、口服液、片剂、胶囊、散剂、丸剂或膏方。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210670878.0A CN115252732B (zh) | 2022-06-08 | 2022-06-08 | 一种清肺止咳的中药组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210670878.0A CN115252732B (zh) | 2022-06-08 | 2022-06-08 | 一种清肺止咳的中药组合物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115252732A true CN115252732A (zh) | 2022-11-01 |
CN115252732B CN115252732B (zh) | 2023-11-14 |
Family
ID=83760176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210670878.0A Active CN115252732B (zh) | 2022-06-08 | 2022-06-08 | 一种清肺止咳的中药组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115252732B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705890A (zh) * | 2013-12-27 | 2014-04-09 | 广西金页制药有限公司 | 一种具有清肺止咳作用的药物组合物 |
CN104435944A (zh) * | 2014-12-24 | 2015-03-25 | 刘安利 | 一种治疗小儿咳嗽的中药组合物及其制备方法 |
CN105816836A (zh) * | 2016-04-26 | 2016-08-03 | 大连大学 | 一种治疗间质性肺炎的中药制剂及其应用 |
-
2022
- 2022-06-08 CN CN202210670878.0A patent/CN115252732B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103705890A (zh) * | 2013-12-27 | 2014-04-09 | 广西金页制药有限公司 | 一种具有清肺止咳作用的药物组合物 |
CN104435944A (zh) * | 2014-12-24 | 2015-03-25 | 刘安利 | 一种治疗小儿咳嗽的中药组合物及其制备方法 |
CN105816836A (zh) * | 2016-04-26 | 2016-08-03 | 大连大学 | 一种治疗间质性肺炎的中药制剂及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN115252732B (zh) | 2023-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103816504A (zh) | 一种活血止痛膏及其制备方法 | |
CN101537160B (zh) | 一种排毒养颜保健品 | |
CN102688384B (zh) | 一种治疗慢性咽炎的中药汤剂 | |
CN105381153A (zh) | 治疗支气管炎的中药制剂及制备方法 | |
CN102657795A (zh) | 一种促进术后刀口愈合的中药制剂 | |
CN115252732B (zh) | 一种清肺止咳的中药组合物及其应用 | |
CN115006492B (zh) | 一种治疗失眠的中药组合物及其应用 | |
CN105125789A (zh) | 治疗胃痛的健脾和胃制剂及制备方法 | |
CN115120690B (zh) | 一种治疗性早熟的中药组合物及其应用 | |
CN100473403C (zh) | 一种治疗癌症的胶囊 | |
CN105250435A (zh) | 一种治疗流行性感冒的中药复方制剂及其制备方法 | |
CN104435162A (zh) | 治疗病毒性肺炎的内服中药制剂 | |
CN103191335B (zh) | 一种治疗食道失弛缓症的药物组合物 | |
CN101757556A (zh) | 一种治疗咽炎的药物及其制备方法 | |
CN103495069A (zh) | 一种治疗产后神经性肠梗阻的药物组合物 | |
CN103191339A (zh) | 一种治疗小儿贲门失弛缓症药物的制备方法 | |
CN103721028A (zh) | 一种治疗心绞痛的药物及制备方法 | |
CN112933135A (zh) | 一种治疗脾胃虚弱的组合物及其应用 | |
CN109453343A (zh) | 一种治疗皮肤疮疹的中药敷剂 | |
CN107789425A (zh) | 一种治疗痔疮的中药口服液及其制备方法 | |
CN104623453A (zh) | 治疗妇女乳痰的药物制剂及制备 | |
CN104667062A (zh) | 一种动脉硬化症患者益气降脂药物 | |
CN104784513A (zh) | 一种治疗慢性扁桃体炎的中药制剂 | |
CN105726896A (zh) | 一种治疗冠心病的中药制剂及制备方法 | |
CN105250728A (zh) | 一种治疗月经不调的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |